Inhibition of the Angiogenic Response

Iruela-Arispe, Luisa

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: First Independent Research Support & Transition (FIRST) Awards (R29)
• Project #: 5R29CA065624-03
• Application #: 2108679
• Study Section: Pathology A Study Section (PTHA)
• Project Start: 1994-04-01
• Project End: 1999-03-31
• Budget Start: 1996-04-01
• Budget End: 1997-03-31
• Support Year: 3
• Fiscal Year: 1996

Institution

• Name: Beth Israel Deaconess Medical Center
• DUNS #: 076593722
• City: Boston
• State: MA
• Country: United States
• Zip Code: 02215

Publications

Rodriguez-Manzaneque, J C; Lane, T F; Ortega, M A et al. (2001) Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor. Proc Natl Acad Sci U S A 98:12485-90